nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—MAP2K5—restless legs syndrome	0.752	1	CbGaD
Sunitinib—PAK3—Focal Adhesion—MAP2K5—restless legs syndrome	0.000622	0.00593	CbGpPWpGaD
Sunitinib—FGFR2—Ectoderm Differentiation—TOX3—restless legs syndrome	0.000618	0.00589	CbGpPWpGaD
Sunitinib—RPS6KA3—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000618	0.00589	CbGpPWpGaD
Sunitinib—MAP3K2—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000617	0.00588	CbGpPWpGaD
Sunitinib—RPS6KA5—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000616	0.00588	CbGpPWpGaD
Sunitinib—RPS6KA2—Insulin Signaling—MAP2K5—restless legs syndrome	0.000616	0.00587	CbGpPWpGaD
Sunitinib—RPS6KA2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00061	0.00582	CbGpPWpGaD
Sunitinib—RPS6KA1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000602	0.00574	CbGpPWpGaD
Sunitinib—RPS6KA5—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000599	0.00571	CbGpPWpGaD
Sunitinib—MAP2K2—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.000582	0.00555	CbGpPWpGaD
Sunitinib—MAP3K2—Insulin Signaling—MAP2K5—restless legs syndrome	0.000567	0.00541	CbGpPWpGaD
Sunitinib—MAP4K1—Insulin Signaling—MAP2K5—restless legs syndrome	0.000567	0.00541	CbGpPWpGaD
Sunitinib—ROCK1—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000567	0.0054	CbGpPWpGaD
Sunitinib—MAP3K2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000561	0.00535	CbGpPWpGaD
Sunitinib—MAP4K1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000561	0.00535	CbGpPWpGaD
Sunitinib—RPS6KA1—Insulin Signaling—MAP2K5—restless legs syndrome	0.000554	0.00528	CbGpPWpGaD
Sunitinib—ABCC4—Ectoderm Differentiation—TOX3—restless legs syndrome	0.000549	0.00523	CbGpPWpGaD
Sunitinib—RPS6KA1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000548	0.00522	CbGpPWpGaD
Sunitinib—MAP3K2—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000545	0.0052	CbGpPWpGaD
Sunitinib—MAP4K1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000545	0.0052	CbGpPWpGaD
Sunitinib—MAP2K1—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.000544	0.00519	CbGpPWpGaD
Sunitinib—RPS6KA5—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000509	0.00485	CbGpPWpGaD
Sunitinib—RPS6KA2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000503	0.0048	CbGpPWpGaD
Sunitinib—FYN—Ectoderm Differentiation—TOX3—restless legs syndrome	0.000499	0.00476	CbGpPWpGaD
Sunitinib—ERN1—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.000499	0.00476	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000493	0.00469	CbGpPWpGaD
Sunitinib—MAP3K3—Insulin Signaling—MAP2K5—restless legs syndrome	0.000488	0.00465	CbGpPWpGaD
Sunitinib—PRKAA1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000484	0.00462	CbGpPWpGaD
Sunitinib—FGFR2—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.000483	0.00461	CbGpPWpGaD
Sunitinib—MAP3K3—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000483	0.0046	CbGpPWpGaD
Sunitinib—RPS6KA3—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.00048	0.00457	CbGpPWpGaD
Sunitinib—FLT1—Focal Adhesion—MAP2K5—restless legs syndrome	0.000479	0.00456	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000459	0.00438	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000458	0.00436	CbGpPWpGaD
Sunitinib—RPS6KA1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000452	0.00431	CbGpPWpGaD
Sunitinib—PRKAA1—Insulin Signaling—MAP2K5—restless legs syndrome	0.000445	0.00424	CbGpPWpGaD
Sunitinib—RPS6KA3—Insulin Signaling—MAP2K5—restless legs syndrome	0.000441	0.0042	CbGpPWpGaD
Sunitinib—PTK2B—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.00044	0.00419	CbGpPWpGaD
Sunitinib—RPS6KA3—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000437	0.00416	CbGpPWpGaD
Sunitinib—RPS6KA3—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000424	0.00404	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000423	0.00403	CbGpPWpGaD
Sunitinib—NTRK1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000421	0.00401	CbGpPWpGaD
Sunitinib—MAP2K2—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.000415	0.00395	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000412	0.00393	CbGpPWpGaD
Sunitinib—RPS6KB1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000408	0.00389	CbGpPWpGaD
Sunitinib—PTK2B—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.0004	0.00381	CbGpPWpGaD
Sunitinib—KIT—Differentiation Pathway—TF—restless legs syndrome	0.000396	0.00378	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000395	0.00377	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling by NGF—MAP2K5—restless legs syndrome	0.000391	0.00373	CbGpPWpGaD
Sunitinib—MAP2K1—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.000388	0.0037	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by NGF—MAP2K5—restless legs syndrome	0.000387	0.00369	CbGpPWpGaD
Sunitinib—ROCK1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000385	0.00367	CbGpPWpGaD
Sunitinib—MAP2K1—EPHB forward signaling—TF—restless legs syndrome	0.000383	0.00365	CbGpPWpGaD
Sunitinib—SBK1—brain—restless legs syndrome	0.00038	0.00266	CbGeAlD
Sunitinib—CSNK2A1—central nervous system—restless legs syndrome	0.000379	0.00266	CbGeAlD
Sunitinib—HIPK4—brain—restless legs syndrome	0.000375	0.00263	CbGeAlD
Sunitinib—RPS6KB1—Insulin Signaling—MAP2K5—restless legs syndrome	0.000375	0.00357	CbGpPWpGaD
Sunitinib—PHKG2—nervous system—restless legs syndrome	0.000374	0.00263	CbGeAlD
Sunitinib—MYLK—central nervous system—restless legs syndrome	0.000374	0.00262	CbGeAlD
Sunitinib—RET—SIDS Susceptibility Pathways—TF—restless legs syndrome	0.000373	0.00355	CbGpPWpGaD
Sunitinib—STK24—nervous system—restless legs syndrome	0.000372	0.00261	CbGeAlD
Sunitinib—NTRK1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000372	0.00355	CbGpPWpGaD
Sunitinib—RPS6KB1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000371	0.00354	CbGpPWpGaD
Sunitinib—PHKG1—brain—restless legs syndrome	0.000371	0.0026	CbGeAlD
Sunitinib—DAPK1—brain—restless legs syndrome	0.000371	0.0026	CbGeAlD
Sunitinib—MAP4K4—spinal cord—restless legs syndrome	0.000369	0.00259	CbGeAlD
Sunitinib—STK4—central nervous system—restless legs syndrome	0.000367	0.00257	CbGeAlD
Sunitinib—MAP3K12—spinal cord—restless legs syndrome	0.000363	0.00255	CbGeAlD
Sunitinib—STK16—nervous system—restless legs syndrome	0.000362	0.00254	CbGeAlD
Sunitinib—MAP2K2—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000361	0.00344	CbGpPWpGaD
Sunitinib—PHKG2—central nervous system—restless legs syndrome	0.00036	0.00253	CbGeAlD
Sunitinib—RPS6KA3—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00036	0.00343	CbGpPWpGaD
Sunitinib—HIPK2—nervous system—restless legs syndrome	0.00036	0.00253	CbGeAlD
Sunitinib—ALK—nervous system—restless legs syndrome	0.00036	0.00253	CbGeAlD
Sunitinib—TYRO3—nervous system—restless legs syndrome	0.00036	0.00253	CbGeAlD
Sunitinib—STK11—brain—restless legs syndrome	0.000359	0.00252	CbGeAlD
Sunitinib—BRD4—brain—restless legs syndrome	0.000359	0.00252	CbGeAlD
Sunitinib—RPS6KA3—spinal cord—restless legs syndrome	0.000358	0.00251	CbGeAlD
Sunitinib—STK24—central nervous system—restless legs syndrome	0.000358	0.00251	CbGeAlD
Sunitinib—RIOK2—nervous system—restless legs syndrome	0.000356	0.0025	CbGeAlD
Sunitinib—MAP2K1—spinal cord—restless legs syndrome	0.000356	0.0025	CbGeAlD
Sunitinib—RPS6KA1—brain—restless legs syndrome	0.000356	0.0025	CbGeAlD
Sunitinib—RIOK1—brain—restless legs syndrome	0.000356	0.0025	CbGeAlD
Sunitinib—MAP3K19—nervous system—restless legs syndrome	0.000353	0.00247	CbGeAlD
Sunitinib—CSNK1A1—spinal cord—restless legs syndrome	0.000351	0.00246	CbGeAlD
Sunitinib—CLK1—spinal cord—restless legs syndrome	0.000349	0.00245	CbGeAlD
Sunitinib—TNIK—brain—restless legs syndrome	0.000349	0.00245	CbGeAlD
Sunitinib—MARK2—brain—restless legs syndrome	0.000349	0.00245	CbGeAlD
Sunitinib—MAP2K5—brainstem—restless legs syndrome	0.000349	0.00245	CbGeAlD
Sunitinib—STK16—central nervous system—restless legs syndrome	0.000349	0.00245	CbGeAlD
Sunitinib—RPS6KA1—Signaling by NGF—MAP2K5—restless legs syndrome	0.000348	0.00332	CbGpPWpGaD
Sunitinib—MAP2K2—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000347	0.00331	CbGpPWpGaD
Sunitinib—TYRO3—central nervous system—restless legs syndrome	0.000347	0.00243	CbGeAlD
Sunitinib—ALK—central nervous system—restless legs syndrome	0.000347	0.00243	CbGeAlD
Sunitinib—HIPK2—central nervous system—restless legs syndrome	0.000347	0.00243	CbGeAlD
Sunitinib—DAPK3—nervous system—restless legs syndrome	0.000346	0.00243	CbGeAlD
Sunitinib—SGK3—brain—restless legs syndrome	0.000346	0.00242	CbGeAlD
Sunitinib—BLK—Focal Adhesion—MAP2K5—restless legs syndrome	0.000344	0.00328	CbGpPWpGaD
Sunitinib—RIOK2—central nervous system—restless legs syndrome	0.000343	0.00241	CbGeAlD
Sunitinib—CLK2—nervous system—restless legs syndrome	0.000343	0.0024	CbGeAlD
Sunitinib—BMP2K—spinal cord—restless legs syndrome	0.000343	0.0024	CbGeAlD
Sunitinib—CAMK2G—spinal cord—restless legs syndrome	0.000343	0.0024	CbGeAlD
Sunitinib—FGR—Focal Adhesion—MAP2K5—restless legs syndrome	0.000343	0.00327	CbGpPWpGaD
Sunitinib—ICK—brain—restless legs syndrome	0.000342	0.0024	CbGeAlD
Sunitinib—MAP3K19—central nervous system—restless legs syndrome	0.00034	0.00238	CbGeAlD
Sunitinib—LRRK2—spinal cord—restless legs syndrome	0.00034	0.00238	CbGeAlD
Sunitinib—FYN—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000339	0.00323	CbGpPWpGaD
Sunitinib—ROCK1—Focal Adhesion—MAP2K5—restless legs syndrome	0.000339	0.00323	CbGpPWpGaD
Sunitinib—MAP2K1—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000337	0.00322	CbGpPWpGaD
Sunitinib—DAPK3—central nervous system—restless legs syndrome	0.000333	0.00234	CbGeAlD
Sunitinib—ROCK1—nervous system—restless legs syndrome	0.000332	0.00233	CbGeAlD
Sunitinib—CHEK2—brain—restless legs syndrome	0.000331	0.00232	CbGeAlD
Sunitinib—NUAK1—brain—restless legs syndrome	0.000331	0.00232	CbGeAlD
Sunitinib—CLK2—central nervous system—restless legs syndrome	0.00033	0.00231	CbGeAlD
Sunitinib—INSR—brain—restless legs syndrome	0.000328	0.0023	CbGeAlD
Sunitinib—OXSR1—brain—restless legs syndrome	0.000328	0.0023	CbGeAlD
Sunitinib—SNRK—brain—restless legs syndrome	0.000328	0.0023	CbGeAlD
Sunitinib—CSNK1E—spinal cord—restless legs syndrome	0.000326	0.00228	CbGeAlD
Sunitinib—FGFR1—spinal cord—restless legs syndrome	0.000326	0.00228	CbGeAlD
Sunitinib—MAP2K1—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000325	0.00309	CbGpPWpGaD
Sunitinib—DYRK1A—nervous system—restless legs syndrome	0.000324	0.00227	CbGeAlD
Sunitinib—STK38—brain—restless legs syndrome	0.000323	0.00226	CbGeAlD
Sunitinib—RPS6KA2—brain—restless legs syndrome	0.000323	0.00226	CbGeAlD
Sunitinib—IRAK4—spinal cord—restless legs syndrome	0.000321	0.00225	CbGeAlD
Sunitinib—AURKC—brain—restless legs syndrome	0.00032	0.00225	CbGeAlD
Sunitinib—ROCK1—central nervous system—restless legs syndrome	0.00032	0.00224	CbGeAlD
Sunitinib—KDR—Focal Adhesion—MAP2K5—restless legs syndrome	0.000318	0.00304	CbGpPWpGaD
Sunitinib—CSNK1G2—brain—restless legs syndrome	0.000318	0.00223	CbGeAlD
Sunitinib—PKN1—brain—restless legs syndrome	0.000318	0.00223	CbGeAlD
Sunitinib—MERTK—nervous system—restless legs syndrome	0.000316	0.00222	CbGeAlD
Sunitinib—NTRK1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000316	0.00301	CbGpPWpGaD
Sunitinib—ULK3—spinal cord—restless legs syndrome	0.000313	0.0022	CbGeAlD
Sunitinib—MAP2K2—spinal cord—restless legs syndrome	0.000313	0.0022	CbGeAlD
Sunitinib—PRPF4—brain—restless legs syndrome	0.000313	0.0022	CbGeAlD
Sunitinib—DYRK1A—central nervous system—restless legs syndrome	0.000312	0.00219	CbGeAlD
Sunitinib—MAP4K4—nervous system—restless legs syndrome	0.000311	0.00218	CbGeAlD
Sunitinib—KIT—brainstem—restless legs syndrome	0.000309	0.00217	CbGeAlD
Sunitinib—PRPF4B—brain—restless legs syndrome	0.000309	0.00217	CbGeAlD
Sunitinib—MAP3K7—spinal cord—restless legs syndrome	0.000308	0.00216	CbGeAlD
Sunitinib—MAP3K12—nervous system—restless legs syndrome	0.000306	0.00215	CbGeAlD
Sunitinib—TBK1—spinal cord—restless legs syndrome	0.000305	0.00214	CbGeAlD
Sunitinib—MERTK—central nervous system—restless legs syndrome	0.000305	0.00214	CbGeAlD
Sunitinib—STK39—brain—restless legs syndrome	0.000305	0.00214	CbGeAlD
Sunitinib—TYK2—spinal cord—restless legs syndrome	0.000303	0.00212	CbGeAlD
Sunitinib—RPS6KA3—nervous system—restless legs syndrome	0.000302	0.00212	CbGeAlD
Sunitinib—CSNK2A1—brain—restless legs syndrome	0.000301	0.00211	CbGeAlD
Sunitinib—MAP2K1—nervous system—restless legs syndrome	0.0003	0.0021	CbGeAlD
Sunitinib—MAP4K4—central nervous system—restless legs syndrome	0.000299	0.0021	CbGeAlD
Sunitinib—MYLK—brain—restless legs syndrome	0.000297	0.00208	CbGeAlD
Sunitinib—CSNK1A1—nervous system—restless legs syndrome	0.000296	0.00208	CbGeAlD
Sunitinib—MAP3K12—central nervous system—restless legs syndrome	0.000295	0.00207	CbGeAlD
Sunitinib—CLK1—nervous system—restless legs syndrome	0.000294	0.00206	CbGeAlD
Sunitinib—RPS6KB1—spinal cord—restless legs syndrome	0.000293	0.00206	CbGeAlD
Sunitinib—PLK4—brain—restless legs syndrome	0.000293	0.00206	CbGeAlD
Sunitinib—RET—spinal cord—restless legs syndrome	0.000291	0.00204	CbGeAlD
Sunitinib—STK4—brain—restless legs syndrome	0.000291	0.00204	CbGeAlD
Sunitinib—FYN—Syndecan-3-mediated signaling events—POMC—restless legs syndrome	0.000291	0.00277	CbGpPWpGaD
Sunitinib—RPS6KA3—central nervous system—restless legs syndrome	0.000291	0.00204	CbGeAlD
Sunitinib—AXL—spinal cord—restless legs syndrome	0.00029	0.00204	CbGeAlD
Sunitinib—MAP2K1—central nervous system—restless legs syndrome	0.000289	0.00203	CbGeAlD
Sunitinib—BMP2K—nervous system—restless legs syndrome	0.000289	0.00203	CbGeAlD
Sunitinib—CAMK2G—nervous system—restless legs syndrome	0.000289	0.00203	CbGeAlD
Sunitinib—ABCG2—Iron uptake and transport—TF—restless legs syndrome	0.000287	0.00274	CbGpPWpGaD
Sunitinib—LRRK2—nervous system—restless legs syndrome	0.000286	0.00201	CbGeAlD
Sunitinib—PHKG2—brain—restless legs syndrome	0.000286	0.00201	CbGeAlD
Sunitinib—CSNK1A1—central nervous system—restless legs syndrome	0.000285	0.002	CbGeAlD
Sunitinib—STK24—brain—restless legs syndrome	0.000284	0.002	CbGeAlD
Sunitinib—MAP3K7—Insulin Signaling—MAP2K5—restless legs syndrome	0.000283	0.0027	CbGpPWpGaD
Sunitinib—CLK1—central nervous system—restless legs syndrome	0.000283	0.00199	CbGeAlD
Sunitinib—PRKAA1—nervous system—restless legs syndrome	0.000282	0.00198	CbGeAlD
Sunitinib—SGK3—Transmembrane transport of small molecules—TF—restless legs syndrome	0.000282	0.00269	CbGpPWpGaD
Sunitinib—DAPK2—brain—restless legs syndrome	0.000281	0.00197	CbGeAlD
Sunitinib—SLK—spinal cord—restless legs syndrome	0.000279	0.00196	CbGeAlD
Sunitinib—PTK2B—nervous system—restless legs syndrome	0.000279	0.00196	CbGeAlD
Sunitinib—BMP2K—central nervous system—restless legs syndrome	0.000278	0.00195	CbGeAlD
Sunitinib—CAMK2G—central nervous system—restless legs syndrome	0.000278	0.00195	CbGeAlD
Sunitinib—RPS6KA3—Signaling by NGF—MAP2K5—restless legs syndrome	0.000277	0.00264	CbGpPWpGaD
Sunitinib—MERTK—Hemostasis—TF—restless legs syndrome	0.000277	0.00264	CbGpPWpGaD
Sunitinib—FGFR2—spinal cord—restless legs syndrome	0.000277	0.00194	CbGeAlD
Sunitinib—STK16—brain—restless legs syndrome	0.000277	0.00194	CbGeAlD
Sunitinib—LRRK2—central nervous system—restless legs syndrome	0.000276	0.00193	CbGeAlD
Sunitinib—JAK2—spinal cord—restless legs syndrome	0.000275	0.00193	CbGeAlD
Sunitinib—ALK—brain—restless legs syndrome	0.000275	0.00193	CbGeAlD
Sunitinib—HIPK3—brain—restless legs syndrome	0.000275	0.00193	CbGeAlD
Sunitinib—HIPK2—brain—restless legs syndrome	0.000275	0.00193	CbGeAlD
Sunitinib—TYRO3—brain—restless legs syndrome	0.000275	0.00193	CbGeAlD
Sunitinib—CSNK1E—nervous system—restless legs syndrome	0.000274	0.00192	CbGeAlD
Sunitinib—MAP3K7—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000273	0.0026	CbGpPWpGaD
Sunitinib—TNK1—brain—restless legs syndrome	0.000272	0.00191	CbGeAlD
Sunitinib—RIOK2—brain—restless legs syndrome	0.000272	0.00191	CbGeAlD
Sunitinib—FYN—spinal cord—restless legs syndrome	0.000272	0.00191	CbGeAlD
Sunitinib—PRKAA1—central nervous system—restless legs syndrome	0.000272	0.0019	CbGeAlD
Sunitinib—IRAK4—nervous system—restless legs syndrome	0.00027	0.00189	CbGeAlD
Sunitinib—MAP3K19—brain—restless legs syndrome	0.00027	0.00189	CbGeAlD
Sunitinib—MAP4K1—brain—restless legs syndrome	0.00027	0.00189	CbGeAlD
Sunitinib—MAP2K2—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000269	0.00257	CbGpPWpGaD
Sunitinib—PTK2B—central nervous system—restless legs syndrome	0.000268	0.00188	CbGeAlD
Sunitinib—MAP3K3—spinal cord—restless legs syndrome	0.000265	0.00186	CbGeAlD
Sunitinib—MAP4K5—spinal cord—restless legs syndrome	0.000265	0.00186	CbGeAlD
Sunitinib—DAPK3—brain—restless legs syndrome	0.000264	0.00186	CbGeAlD
Sunitinib—CSNK1E—central nervous system—restless legs syndrome	0.000264	0.00185	CbGeAlD
Sunitinib—MAP2K2—nervous system—restless legs syndrome	0.000264	0.00185	CbGeAlD
Sunitinib—ULK3—nervous system—restless legs syndrome	0.000264	0.00185	CbGeAlD
Sunitinib—MAP3K2—nervous system—restless legs syndrome	0.000262	0.00184	CbGeAlD
Sunitinib—CLK2—brain—restless legs syndrome	0.000262	0.00184	CbGeAlD
Sunitinib—MAP4K2—brain—restless legs syndrome	0.000261	0.00183	CbGeAlD
Sunitinib—IRAK4—central nervous system—restless legs syndrome	0.00026	0.00182	CbGeAlD
Sunitinib—FGFR1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000259	0.00247	CbGpPWpGaD
Sunitinib—STK3—brain—restless legs syndrome	0.000257	0.0018	CbGeAlD
Sunitinib—TBK1—nervous system—restless legs syndrome	0.000257	0.0018	CbGeAlD
Sunitinib—FLT1—spinal cord—restless legs syndrome	0.000257	0.0018	CbGeAlD
Sunitinib—TYK2—nervous system—restless legs syndrome	0.000255	0.00179	CbGeAlD
Sunitinib—MAP2K2—central nervous system—restless legs syndrome	0.000254	0.00178	CbGeAlD
Sunitinib—ULK3—central nervous system—restless legs syndrome	0.000254	0.00178	CbGeAlD
Sunitinib—ROCK1—brain—restless legs syndrome	0.000254	0.00178	CbGeAlD
Sunitinib—EPHB6—spinal cord—restless legs syndrome	0.000254	0.00178	CbGeAlD
Sunitinib—FYN—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000253	0.00242	CbGpPWpGaD
Sunitinib—MAP3K2—central nervous system—restless legs syndrome	0.000252	0.00177	CbGeAlD
Sunitinib—PRKAA2—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.000252	0.0024	CbGpPWpGaD
Sunitinib—MAP2K1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000252	0.0024	CbGpPWpGaD
Sunitinib—MAP2K2—Insulin Signaling—MAP2K5—restless legs syndrome	0.000248	0.00236	CbGpPWpGaD
Sunitinib—DYRK1A—brain—restless legs syndrome	0.000248	0.00174	CbGeAlD
Sunitinib—TBK1—central nervous system—restless legs syndrome	0.000247	0.00173	CbGeAlD
Sunitinib—RPS6KB1—nervous system—restless legs syndrome	0.000247	0.00173	CbGeAlD
Sunitinib—TYK2—central nervous system—restless legs syndrome	0.000246	0.00172	CbGeAlD
Sunitinib—RET—nervous system—restless legs syndrome	0.000246	0.00172	CbGeAlD
Sunitinib—FGR—nervous system—restless legs syndrome	0.000246	0.00172	CbGeAlD
Sunitinib—MAP2K2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000245	0.00234	CbGpPWpGaD
Sunitinib—YES1—spinal cord—restless legs syndrome	0.000245	0.00172	CbGeAlD
Sunitinib—AXL—nervous system—restless legs syndrome	0.000245	0.00172	CbGeAlD
Sunitinib—NTRK1—Signaling by NGF—MAP2K5—restless legs syndrome	0.000243	0.00232	CbGpPWpGaD
Sunitinib—TAOK3—spinal cord—restless legs syndrome	0.000242	0.0017	CbGeAlD
Sunitinib—MERTK—brain—restless legs syndrome	0.000242	0.0017	CbGeAlD
Sunitinib—JAK2—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000241	0.0023	CbGpPWpGaD
Sunitinib—PDGFRA—spinal cord—restless legs syndrome	0.00024	0.00169	CbGeAlD
Sunitinib—TYK2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000239	0.00228	CbGpPWpGaD
Sunitinib—ABCC4—Platelet degranulation—TF—restless legs syndrome	0.000238	0.00227	CbGpPWpGaD
Sunitinib—MAP2K2—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000238	0.00227	CbGpPWpGaD
Sunitinib—RPS6KB1—central nervous system—restless legs syndrome	0.000238	0.00167	CbGeAlD
Sunitinib—MAP4K4—brain—restless legs syndrome	0.000237	0.00167	CbGeAlD
Sunitinib—FGR—central nervous system—restless legs syndrome	0.000236	0.00166	CbGeAlD
Sunitinib—RET—central nervous system—restless legs syndrome	0.000236	0.00166	CbGeAlD
Sunitinib—FGFR2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000236	0.00225	CbGpPWpGaD
Sunitinib—NUAK2—brain—restless legs syndrome	0.000236	0.00165	CbGeAlD
Sunitinib—AXL—central nervous system—restless legs syndrome	0.000235	0.00165	CbGeAlD
Sunitinib—MAP3K12—brain—restless legs syndrome	0.000234	0.00164	CbGeAlD
Sunitinib—PDGFRA—Focal Adhesion—MAP2K5—restless legs syndrome	0.000234	0.00223	CbGpPWpGaD
Sunitinib—FGFR2—nervous system—restless legs syndrome	0.000233	0.00164	CbGeAlD
Sunitinib—PDGFRB—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000232	0.00222	CbGpPWpGaD
Sunitinib—JAK2—nervous system—restless legs syndrome	0.000232	0.00163	CbGeAlD
Sunitinib—LATS2—Signaling Pathways—MAP2K5—restless legs syndrome	0.000232	0.00221	CbGpPWpGaD
Sunitinib—MAP2K1—Insulin Signaling—MAP2K5—restless legs syndrome	0.000232	0.00221	CbGpPWpGaD
Sunitinib—KIT—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000231	0.00221	CbGpPWpGaD
Sunitinib—RPS6KA3—brain—restless legs syndrome	0.000231	0.00162	CbGeAlD
Sunitinib—MAP2K1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000229	0.00219	CbGpPWpGaD
Sunitinib—MAP2K1—brain—restless legs syndrome	0.000229	0.00161	CbGeAlD
Sunitinib—FYN—nervous system—restless legs syndrome	0.000229	0.00161	CbGeAlD
Sunitinib—ABCC4—Response to elevated platelet cytosolic Ca2+—TF—restless legs syndrome	0.000227	0.00216	CbGpPWpGaD
Sunitinib—CSNK1A1—brain—restless legs syndrome	0.000226	0.00159	CbGeAlD
Sunitinib—CLK1—brain—restless legs syndrome	0.000225	0.00158	CbGeAlD
Sunitinib—FGFR2—central nervous system—restless legs syndrome	0.000225	0.00158	CbGeAlD
Sunitinib—MAP3K3—nervous system—restless legs syndrome	0.000224	0.00157	CbGeAlD
Sunitinib—MAP4K5—nervous system—restless legs syndrome	0.000224	0.00157	CbGeAlD
Sunitinib—JAK2—central nervous system—restless legs syndrome	0.000223	0.00157	CbGeAlD
Sunitinib—MAP2K1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000223	0.00212	CbGpPWpGaD
Sunitinib—CAMK2G—brain—restless legs syndrome	0.000221	0.00155	CbGeAlD
Sunitinib—BMP2K—brain—restless legs syndrome	0.000221	0.00155	CbGeAlD
Sunitinib—FYN—central nervous system—restless legs syndrome	0.00022	0.00155	CbGeAlD
Sunitinib—FGFR1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00022	0.00209	CbGpPWpGaD
Sunitinib—JAK2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000219	0.00209	CbGpPWpGaD
Sunitinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000219	0.00209	CbGpPWpGaD
Sunitinib—LRRK2—brain—restless legs syndrome	0.000219	0.00153	CbGeAlD
Sunitinib—MAP2K5—spinal cord—restless legs syndrome	0.000217	0.00152	CbGeAlD
Sunitinib—KDR—spinal cord—restless legs syndrome	0.000217	0.00152	CbGeAlD
Sunitinib—FLT1—nervous system—restless legs syndrome	0.000216	0.00152	CbGeAlD
Sunitinib—MAP2K2—Focal Adhesion—MAP2K5—restless legs syndrome	0.000216	0.00206	CbGpPWpGaD
Sunitinib—PRKAA1—brain—restless legs syndrome	0.000216	0.00151	CbGeAlD
Sunitinib—MAP3K3—central nervous system—restless legs syndrome	0.000215	0.00151	CbGeAlD
Sunitinib—MAP4K5—central nervous system—restless legs syndrome	0.000215	0.00151	CbGeAlD
Sunitinib—EPHB6—nervous system—restless legs syndrome	0.000214	0.0015	CbGeAlD
Sunitinib—PTK2B—brain—restless legs syndrome	0.000213	0.0015	CbGeAlD
Sunitinib—FLT4—brain—restless legs syndrome	0.000213	0.00149	CbGeAlD
Sunitinib—CSF1R—spinal cord—restless legs syndrome	0.000212	0.00149	CbGeAlD
Sunitinib—PDGFRB—Focal Adhesion—MAP2K5—restless legs syndrome	0.000211	0.00201	CbGpPWpGaD
Sunitinib—CSNK1E—brain—restless legs syndrome	0.00021	0.00147	CbGeAlD
Sunitinib—FGFR1—brain—restless legs syndrome	0.00021	0.00147	CbGeAlD
Sunitinib—FLT1—central nervous system—restless legs syndrome	0.000208	0.00146	CbGeAlD
Sunitinib—YES1—nervous system—restless legs syndrome	0.000207	0.00145	CbGeAlD
Sunitinib—IRAK4—brain—restless legs syndrome	0.000206	0.00145	CbGeAlD
Sunitinib—EPHB6—central nervous system—restless legs syndrome	0.000206	0.00144	CbGeAlD
Sunitinib—STK10—nervous system—restless legs syndrome	0.000205	0.00144	CbGeAlD
Sunitinib—TAOK3—nervous system—restless legs syndrome	0.000204	0.00143	CbGeAlD
Sunitinib—ABCG2—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.000204	0.00194	CbGpPWpGaD
Sunitinib—FYN—Focal Adhesion—MAP2K5—restless legs syndrome	0.000203	0.00194	CbGpPWpGaD
Sunitinib—PDGFRA—nervous system—restless legs syndrome	0.000203	0.00142	CbGeAlD
Sunitinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000202	0.00193	CbGpPWpGaD
Sunitinib—MAP2K1—Focal Adhesion—MAP2K5—restless legs syndrome	0.000202	0.00192	CbGpPWpGaD
Sunitinib—ULK3—brain—restless legs syndrome	0.000202	0.00142	CbGeAlD
Sunitinib—MAP2K2—brain—restless legs syndrome	0.000202	0.00142	CbGeAlD
Sunitinib—MAP3K2—brain—restless legs syndrome	0.0002	0.00141	CbGeAlD
Sunitinib—YES1—central nervous system—restless legs syndrome	0.000199	0.0014	CbGeAlD
Sunitinib—MAP3K7—brain—restless legs syndrome	0.000199	0.00139	CbGeAlD
Sunitinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000197	0.00188	CbGpPWpGaD
Sunitinib—STK10—central nervous system—restless legs syndrome	0.000197	0.00138	CbGeAlD
Sunitinib—TAOK3—central nervous system—restless legs syndrome	0.000196	0.00138	CbGeAlD
Sunitinib—TBK1—brain—restless legs syndrome	0.000196	0.00138	CbGeAlD
Sunitinib—PDGFRA—central nervous system—restless legs syndrome	0.000195	0.00137	CbGeAlD
Sunitinib—TYK2—brain—restless legs syndrome	0.000195	0.00137	CbGeAlD
Sunitinib—IRAK1—brain—restless legs syndrome	0.000192	0.00135	CbGeAlD
Sunitinib—KIT—spinal cord—restless legs syndrome	0.000192	0.00135	CbGeAlD
Sunitinib—FYN—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00019	0.00181	CbGpPWpGaD
Sunitinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000189	0.0018	CbGpPWpGaD
Sunitinib—IRAK1—Signaling by NGF—MAP2K5—restless legs syndrome	0.000189	0.0018	CbGpPWpGaD
Sunitinib—RPS6KB1—brain—restless legs syndrome	0.000189	0.00132	CbGeAlD
Sunitinib—PDGFRB—spinal cord—restless legs syndrome	0.000188	0.00132	CbGeAlD
Sunitinib—RET—brain—restless legs syndrome	0.000188	0.00132	CbGeAlD
Sunitinib—FGR—brain—restless legs syndrome	0.000188	0.00132	CbGeAlD
Sunitinib—AXL—brain—restless legs syndrome	0.000187	0.00131	CbGeAlD
Sunitinib—TYK2—Signaling by NGF—MAP2K5—restless legs syndrome	0.000184	0.00175	CbGpPWpGaD
Sunitinib—KDR—nervous system—restless legs syndrome	0.000183	0.00128	CbGeAlD
Sunitinib—MAP2K5—nervous system—restless legs syndrome	0.000183	0.00128	CbGeAlD
Sunitinib—FGFR2—Signaling by NGF—MAP2K5—restless legs syndrome	0.000181	0.00173	CbGpPWpGaD
Sunitinib—JAK2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000181	0.00172	CbGpPWpGaD
Sunitinib—SLK—brain—restless legs syndrome	0.00018	0.00126	CbGeAlD
Sunitinib—CSF1R—nervous system—restless legs syndrome	0.000178	0.00125	CbGeAlD
Sunitinib—FGFR2—brain—restless legs syndrome	0.000178	0.00125	CbGeAlD
Sunitinib—KIT—Signaling by NGF—MAP2K5—restless legs syndrome	0.000178	0.0017	CbGpPWpGaD
Sunitinib—JAK2—brain—restless legs syndrome	0.000177	0.00124	CbGeAlD
Sunitinib—KDR—central nervous system—restless legs syndrome	0.000176	0.00123	CbGeAlD
Sunitinib—MAP2K5—central nervous system—restless legs syndrome	0.000176	0.00123	CbGeAlD
Sunitinib—STK4—Signaling Pathways—MAP2K5—restless legs syndrome	0.000176	0.00168	CbGpPWpGaD
Sunitinib—FYN—brain—restless legs syndrome	0.000175	0.00123	CbGeAlD
Sunitinib—CSF1R—central nervous system—restless legs syndrome	0.000172	0.0012	CbGeAlD
Sunitinib—MAP3K3—brain—restless legs syndrome	0.000171	0.0012	CbGeAlD
Sunitinib—MAP4K5—brain—restless legs syndrome	0.000171	0.0012	CbGeAlD
Sunitinib—FGFR1—Signaling by NGF—MAP2K5—restless legs syndrome	0.000169	0.00161	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling by NGF—MAP2K5—restless legs syndrome	0.000169	0.00161	CbGpPWpGaD
Sunitinib—FLT1—brain—restless legs syndrome	0.000165	0.00116	CbGeAlD
Sunitinib—EPHB6—brain—restless legs syndrome	0.000163	0.00115	CbGeAlD
Sunitinib—KCNH2—SIDS Susceptibility Pathways—TF—restless legs syndrome	0.000162	0.00155	CbGpPWpGaD
Sunitinib—KIT—nervous system—restless legs syndrome	0.000162	0.00114	CbGeAlD
Sunitinib—PDGFRB—nervous system—restless legs syndrome	0.000158	0.00111	CbGeAlD
Sunitinib—YES1—brain—restless legs syndrome	0.000158	0.00111	CbGeAlD
Sunitinib—STK10—brain—restless legs syndrome	0.000156	0.0011	CbGeAlD
Sunitinib—KIT—central nervous system—restless legs syndrome	0.000156	0.00109	CbGeAlD
Sunitinib—TAOK3—brain—restless legs syndrome	0.000156	0.00109	CbGeAlD
Sunitinib—MAP2K2—Signaling by NGF—MAP2K5—restless legs syndrome	0.000156	0.00148	CbGpPWpGaD
Sunitinib—PDGFRA—brain—restless legs syndrome	0.000155	0.00109	CbGeAlD
Sunitinib—PDGFRB—central nervous system—restless legs syndrome	0.000152	0.00107	CbGeAlD
Sunitinib—PDGFRB—Signaling by NGF—MAP2K5—restless legs syndrome	0.000152	0.00145	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—MAP2K5—restless legs syndrome	0.00015	0.00143	CbGpPWpGaD
Sunitinib—FYN—Signaling by NGF—MAP2K5—restless legs syndrome	0.000146	0.0014	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by NGF—MAP2K5—restless legs syndrome	0.000146	0.00139	CbGpPWpGaD
Sunitinib—KDR—brain—restless legs syndrome	0.00014	0.00098	CbGeAlD
Sunitinib—MAP2K5—brain—restless legs syndrome	0.00014	0.00098	CbGeAlD
Sunitinib—JAK2—Signaling by NGF—MAP2K5—restless legs syndrome	0.000139	0.00133	CbGpPWpGaD
Sunitinib—CSF1R—brain—restless legs syndrome	0.000136	0.000957	CbGeAlD
Sunitinib—ABCC4—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.000127	0.00121	CbGpPWpGaD
Sunitinib—ABCC4—nervous system—restless legs syndrome	0.000126	0.000884	CbGeAlD
Sunitinib—GRK1—Signaling Pathways—MAP2K5—restless legs syndrome	0.000125	0.00119	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—MAP2K5—restless legs syndrome	0.000125	0.00119	CbGpPWpGaD
Sunitinib—KIT—brain—restless legs syndrome	0.000124	0.000869	CbGeAlD
Sunitinib—ABCC4—central nervous system—restless legs syndrome	0.000121	0.000851	CbGeAlD
Sunitinib—PDGFRB—brain—restless legs syndrome	0.000121	0.000848	CbGeAlD
Sunitinib—AXL—Signaling Pathways—MAP2K5—restless legs syndrome	0.000119	0.00113	CbGpPWpGaD
Sunitinib—KCNH2—spinal cord—restless legs syndrome	0.000119	0.000832	CbGeAlD
Sunitinib—PIP4K2B—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.000116	0.00111	CbGpPWpGaD
Sunitinib—ABCB1—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.00011	0.00105	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—MAP2K5—restless legs syndrome	0.000109	0.00104	CbGpPWpGaD
Sunitinib—ABCC2—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.000107	0.00102	CbGpPWpGaD
Sunitinib—ABCC4—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000106	0.00101	CbGpPWpGaD
Sunitinib—ABCG2—spinal cord—restless legs syndrome	0.000106	0.00074	CbGeAlD
Sunitinib—INSR—Signaling Pathways—MAP2K5—restless legs syndrome	0.000105	0.000997	CbGpPWpGaD
Sunitinib—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.0001	0.000957	CbGpPWpGaD
Sunitinib—ERN1—Metabolism of proteins—POMC—restless legs syndrome	0.0001	0.000957	CbGpPWpGaD
Sunitinib—KCNH2—nervous system—restless legs syndrome	0.0001	0.000701	CbGeAlD
Sunitinib—CSNK2A1—Signaling Pathways—MAP2K5—restless legs syndrome	9.94e-05	0.000947	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—MAP2K5—restless legs syndrome	9.94e-05	0.000947	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—MAP2K5—restless legs syndrome	9.63e-05	0.000918	CbGpPWpGaD
Sunitinib—ABCC4—brain—restless legs syndrome	9.63e-05	0.000675	CbGeAlD
Sunitinib—KCNH2—central nervous system—restless legs syndrome	9.62e-05	0.000675	CbGeAlD
Sunitinib—FYN—Platelet activation, signaling and aggregation—TF—restless legs syndrome	9.6e-05	0.000916	CbGpPWpGaD
Sunitinib—ABCG2—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	9.34e-05	0.00089	CbGpPWpGaD
Sunitinib—JAK2—Platelet activation, signaling and aggregation—TF—restless legs syndrome	9.13e-05	0.00087	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—MAP2K5—restless legs syndrome	8.89e-05	0.000848	CbGpPWpGaD
Sunitinib—MAP2K1—Corticotropin-releasing hormone—POMC—restless legs syndrome	8.87e-05	0.000846	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—MAP2K5—restless legs syndrome	8.4e-05	0.000801	CbGpPWpGaD
Sunitinib—FGR—Hemostasis—TF—restless legs syndrome	8.36e-05	0.000796	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—MAP2K5—restless legs syndrome	8.32e-05	0.000793	CbGpPWpGaD
Sunitinib—CSNK1G2—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	8.27e-05	0.000789	CbGpPWpGaD
Sunitinib—CYP3A7—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	8.14e-05	0.000776	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—MAP2K5—restless legs syndrome	7.92e-05	0.000755	CbGpPWpGaD
Sunitinib—KCNH2—brain—restless legs syndrome	7.64e-05	0.000536	CbGeAlD
Sunitinib—RPS6KA1—Signaling Pathways—MAP2K5—restless legs syndrome	7.47e-05	0.000712	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—MAP2K5—restless legs syndrome	7.41e-05	0.000707	CbGpPWpGaD
Sunitinib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	7.26e-05	0.000692	CbGpPWpGaD
Sunitinib—ABCG2—brain—restless legs syndrome	6.8e-05	0.000477	CbGeAlD
Sunitinib—YES1—Hemostasis—TF—restless legs syndrome	6.74e-05	0.000643	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MAP2K5—restless legs syndrome	6.4e-05	0.00061	CbGpPWpGaD
Sunitinib—CYP3A4—nervous system—restless legs syndrome	6.19e-05	0.000435	CbGeAlD
Sunitinib—PRKAA1—Signaling Pathways—MAP2K5—restless legs syndrome	6.01e-05	0.000573	CbGpPWpGaD
Sunitinib—CYP3A4—central nervous system—restless legs syndrome	5.96e-05	0.000418	CbGeAlD
Sunitinib—RPS6KA3—Signaling Pathways—MAP2K5—restless legs syndrome	5.95e-05	0.000567	CbGpPWpGaD
Sunitinib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	5.88e-05	0.000561	CbGpPWpGaD
Sunitinib—PRKAA2—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	5.87e-05	0.00056	CbGpPWpGaD
Sunitinib—LATS2—Signaling Pathways—POMC—restless legs syndrome	5.71e-05	0.000544	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MAP2K5—restless legs syndrome	5.45e-05	0.00052	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—TF—restless legs syndrome	5.45e-05	0.000519	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MAP2K5—restless legs syndrome	5.25e-05	0.000501	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MAP2K5—restless legs syndrome	5.22e-05	0.000498	CbGpPWpGaD
Sunitinib—ABCB1—spinal cord—restless legs syndrome	5.2e-05	0.000365	CbGeAlD
Sunitinib—PIP4K2B—Metabolism—POMC—restless legs syndrome	5.17e-05	0.000493	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MAP2K5—restless legs syndrome	5.06e-05	0.000482	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	5.05e-05	0.000481	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—TF—restless legs syndrome	4.95e-05	0.000472	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MAP2K5—restless legs syndrome	4.93e-05	0.00047	CbGpPWpGaD
Sunitinib—ABCC4—Transmembrane transport of small molecules—TF—restless legs syndrome	4.71e-05	0.000449	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—TF—restless legs syndrome	4.71e-05	0.000449	CbGpPWpGaD
Sunitinib—ABCB1—nervous system—restless legs syndrome	4.38e-05	0.000308	CbGeAlD
Sunitinib—STK4—Signaling Pathways—POMC—restless legs syndrome	4.32e-05	0.000412	CbGpPWpGaD
Sunitinib—CYP3A7—Biological oxidations—POMC—restless legs syndrome	4.32e-05	0.000412	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MAP2K5—restless legs syndrome	4.28e-05	0.000408	CbGpPWpGaD
Sunitinib—ABCB1—central nervous system—restless legs syndrome	4.22e-05	0.000296	CbGeAlD
Sunitinib—IRAK1—Signaling Pathways—MAP2K5—restless legs syndrome	4.06e-05	0.000387	CbGpPWpGaD
Sunitinib—ABCC2—Transmembrane transport of small molecules—TF—restless legs syndrome	3.97e-05	0.000379	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAP2K5—restless legs syndrome	3.94e-05	0.000376	CbGpPWpGaD
Sunitinib—PHKG1—Metabolism—POMC—restless legs syndrome	3.92e-05	0.000374	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAP2K5—restless legs syndrome	3.89e-05	0.000371	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAP2K5—restless legs syndrome	3.82e-05	0.000365	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAP2K5—restless legs syndrome	3.82e-05	0.000365	CbGpPWpGaD
Sunitinib—CSNK1G2—Metabolism—POMC—restless legs syndrome	3.69e-05	0.000351	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—POMC—restless legs syndrome	3.68e-05	0.000351	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAP2K5—restless legs syndrome	3.63e-05	0.000346	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAP2K5—restless legs syndrome	3.62e-05	0.000345	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by GPCR—POMC—restless legs syndrome	3.46e-05	0.00033	CbGpPWpGaD
Sunitinib—ABCG2—Transmembrane transport of small molecules—TF—restless legs syndrome	3.46e-05	0.00033	CbGpPWpGaD
Sunitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	3.37e-05	0.000322	CbGpPWpGaD
Sunitinib—ABCB1—brain—restless legs syndrome	3.35e-05	0.000235	CbGeAlD
Sunitinib—MAP2K2—Signaling Pathways—MAP2K5—restless legs syndrome	3.34e-05	0.000319	CbGpPWpGaD
Sunitinib—PHKG2—Metabolism—POMC—restless legs syndrome	3.33e-05	0.000318	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAP2K5—restless legs syndrome	3.26e-05	0.000311	CbGpPWpGaD
Sunitinib—STK11—Metabolism—POMC—restless legs syndrome	3.2e-05	0.000305	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAP2K5—restless legs syndrome	3.14e-05	0.0003	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAP2K5—restless legs syndrome	3.13e-05	0.000298	CbGpPWpGaD
Sunitinib—CYP3A5—Biological oxidations—POMC—restless legs syndrome	3.12e-05	0.000298	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—POMC—restless legs syndrome	3.11e-05	0.000296	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—POMC—restless legs syndrome	3.08e-05	0.000294	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—POMC—restless legs syndrome	3.08e-05	0.000294	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAP2K5—restless legs syndrome	2.99e-05	0.000285	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—POMC—restless legs syndrome	2.92e-05	0.000278	CbGpPWpGaD
Sunitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	2.73e-05	0.000261	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—POMC—restless legs syndrome	2.67e-05	0.000255	CbGpPWpGaD
Sunitinib—PRKAA2—Metabolism—POMC—restless legs syndrome	2.62e-05	0.000249	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—POMC—restless legs syndrome	2.57e-05	0.000245	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—POMC—restless legs syndrome	2.48e-05	0.000236	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—POMC—restless legs syndrome	2.44e-05	0.000233	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—POMC—restless legs syndrome	2.44e-05	0.000233	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—POMC—restless legs syndrome	2.41e-05	0.00023	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—POMC—restless legs syndrome	2.37e-05	0.000226	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—POMC—restless legs syndrome	2.19e-05	0.000208	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—POMC—restless legs syndrome	2.19e-05	0.000208	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—POMC—restless legs syndrome	2.07e-05	0.000197	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—POMC—restless legs syndrome	2.05e-05	0.000195	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—POMC—restless legs syndrome	1.95e-05	0.000186	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—TF—restless legs syndrome	1.87e-05	0.000178	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—POMC—restless legs syndrome	1.84e-05	0.000175	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—POMC—restless legs syndrome	1.82e-05	0.000174	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—POMC—restless legs syndrome	1.64e-05	0.000156	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—POMC—restless legs syndrome	1.57e-05	0.00015	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—POMC—restless legs syndrome	1.48e-05	0.000141	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—POMC—restless legs syndrome	1.46e-05	0.00014	CbGpPWpGaD
Sunitinib—CYP3A4—Biological oxidations—POMC—restless legs syndrome	1.45e-05	0.000138	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—POMC—restless legs syndrome	1.39e-05	0.000133	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—POMC—restless legs syndrome	1.37e-05	0.000131	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—POMC—restless legs syndrome	1.34e-05	0.000128	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—POMC—restless legs syndrome	1.3e-05	0.000124	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—POMC—restless legs syndrome	1.29e-05	0.000123	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—POMC—restless legs syndrome	1.28e-05	0.000122	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—POMC—restless legs syndrome	1.24e-05	0.000119	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—POMC—restless legs syndrome	1.24e-05	0.000119	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—POMC—restless legs syndrome	1.24e-05	0.000119	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—POMC—restless legs syndrome	1.21e-05	0.000116	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—POMC—restless legs syndrome	1.05e-05	0.0001	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—POMC—restless legs syndrome	9.99e-06	9.52e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—POMC—restless legs syndrome	9.7e-06	9.24e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—POMC—restless legs syndrome	9.58e-06	9.13e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—POMC—restless legs syndrome	9.41e-06	8.97e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—POMC—restless legs syndrome	9.41e-06	8.97e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—POMC—restless legs syndrome	8.93e-06	8.51e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—POMC—restless legs syndrome	8.9e-06	8.49e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—POMC—restless legs syndrome	8.22e-06	7.84e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—POMC—restless legs syndrome	8.02e-06	7.65e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—POMC—restless legs syndrome	7.73e-06	7.37e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—POMC—restless legs syndrome	7.69e-06	7.33e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—POMC—restless legs syndrome	7.46e-06	7.11e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—POMC—restless legs syndrome	7.39e-06	7.05e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—POMC—restless legs syndrome	7.35e-06	7.01e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—POMC—restless legs syndrome	5.34e-06	5.09e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—POMC—restless legs syndrome	4.03e-06	3.84e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—POMC—restless legs syndrome	2.48e-06	2.37e-05	CbGpPWpGaD
